Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

TVTX holding history

Travere Therapeutics, Inc. in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TVTX overviewAll 13F holders of TVTXFull Q2 2026 holdings

Shares (Q2 2026)
109,807
Value
$6.24M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of TVTX by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026109,807$6.24M<0.1%−90,304−45.1%ReducedHolders
Q1 2026200,111$5.95M<0.1%−119,547−37.4%ReducedHolders
Q4 2025319,658$12.2M<0.1%+205,181+179.2%AddedHolders
Q3 2025114,477$2.74M<0.1%−364,917−76.1%ReducedHolders
Q2 2025479,394$7.10M<0.1%+262,370+120.9%AddedHolders
Q1 2025217,024$3.89M<0.1%+199,468+1,136.2%AddedHolders
Q4 202417,556$305.8K<0.1%−11,006−38.5%ReducedHolders
Q3 202428,562$399.6K<0.1%+12,982+83.3%AddedHolders
Q2 202415,580$128.1K<0.1%−8,491−35.3%ReducedHolders
Q1 202424,071$185.6K<0.1%−101,708−80.9%ReducedHolders
Q4 2023125,779$1.13M<0.1%+97,354+342.5%AddedHolders
Q3 202328,425$254.1K<0.1%−131,873−82.3%ReducedHolders
Q2 2023160,298$2.46M<0.1%+1,478+0.9%AddedHolders
Q1 2023158,820$3.57M<0.1%+144,584+1,015.6%AddedHolders
Q4 202214,236$299.4K<0.1%−30,487−68.2%ReducedHolders
Q3 202244,723$1.10M<0.1%+30,360+211.4%AddedHolders
Q2 202214,363$348.0K<0.1%+14,363NewHolders
Q4 20210$00.0%−13,069−100.0%Sold outHolders
Q3 202113,069$317.0K<0.1%−45,061−77.5%ReducedHolders
Q2 202158,130$848.0K<0.1%+27,621+90.5%AddedHolders
Q1 202130,509$762.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.